Page last updated: 2024-09-05

tolvaptan and Cardiac Remodeling, Ventricular

tolvaptan has been researched along with Cardiac Remodeling, Ventricular in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiki, H; Hanatani, A; Iwao, H; Izumi, Y; Miura, K; Nakamura, Y; Osada-Oka, M; Shimada, K; Shiota, M; Yamazaki, T; Yoshiyama, M1
Iwao, H; Izumi, Y; Miura, K1
Akahoshi, Y; Fujiki, H; Ikeda, T; Iwanaga, Y; Miyazaki, S; Morooka, H; Watanabe, H1
Eguchi, A; Hirotani, S; Iwasaku, T; Mano, T; Masuyama, T; Naito, Y; Okuhara, Y1
Rossi, GP1
Flores, E; Ibrahim, H; Katz, S; Konstam, MA; Koshkarian, G; Kronenberg, MW; McGrew, FA; O'Brien, T; Orlandi, C; Udelson, JE; Zimmer, C1
Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Veeraveedu, PT; Watanabe, K; Yamaguchi, K1

Reviews

1 review(s) available for tolvaptan and Cardiac Remodeling, Ventricular

ArticleYear
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
    Journal of pharmacological sciences, 2014, Volume: 124, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling

2014

Trials

1 trial(s) available for tolvaptan and Cardiac Remodeling, Ventricular

ArticleYear
Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Journal of the American College of Cardiology, 2007, Jun-05, Volume: 49, Issue:22

    Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Dilatation, Pathologic; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Receptors, Vasopressin; Systole; Tolvaptan; Ventricular Function, Left; Ventricular Remodeling

2007

Other Studies

5 other study(ies) available for tolvaptan and Cardiac Remodeling, Ventricular

ArticleYear
Tolvaptan attenuates left ventricular fibrosis after acute myocardial infarction in rats.
    Journal of pharmacological sciences, 2013, Sep-20, Volume: 123, Issue:1

    Topics: Acute-Phase Reaction; Animals; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Furosemide; Heart Failure; Heart Ventricles; Male; Myocardial Infarction; Rats; Rats, Wistar; Tolvaptan; Ventricular Dysfunction, Left; Ventricular Remodeling

2013
Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
    Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Male; Piperidines; Quinolones; Rats, Inbred Dahl; Receptors, Vasopressin; Time Factors; Tolvaptan; Ventricular Function, Left; Ventricular Remodeling

2015
Long-term administration of tolvaptan increases myocardial remodeling and mortality via exacerbation of congestion in mice heart failure model after myocardial infarction.
    International journal of cardiology, 2016, Oct-15, Volume: 221

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Heart Failure; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Mortality; Myocardial Infarction; Random Allocation; Time Factors; Tolvaptan; Ventricular Remodeling

2016
Arginine vasopressin receptor antagonists for heart failure: a winter climbing to the Everest's tip?
    Journal of the American College of Cardiology, 2007, Jun-05, Volume: 49, Issue:22

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Receptors, Vasopressin; Seasons; Tolvaptan; Ventricular Remodeling

2007
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Biochemical pharmacology, 2008, Mar-15, Volume: 75, Issue:6

    Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Creatinine; Diuretics; Echocardiography; Furosemide; Heart Failure; Heart Rate; Male; Organ Size; Osmolar Concentration; Potassium; Rats; Rats, Inbred Lew; Renin; Sodium; Tolvaptan; Ventricular Remodeling

2008